UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 15, 2007
Health Net, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-12718 | 95-4288333 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
21650 Oxnard Street
Woodland Hills, CA 91367
(Address of principal executive offices, zip code)
(818) 676-6000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 1.01 | Entry into a Material Definitive Agreement |
On May 15, 2007, Health Net, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities Inc., Banc of America Securities LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $300,000,000 aggregate principal amount of its 6.375% Senior Notes due 2017 (the “Notes”). The Notes will be issued pursuant to an Indenture (the “Indenture”), dated May 18, 2007, by and between the Company and The Bank of New York Trust Company, N.A., as trustee, as supplemented by an Officer’s Certificate, dated May 18, 2007 (the “Officer’s Certificate”).
The Notes will bear interest at the rate of 6.375% per year. Interest on the Notes is payable on June 1 and December 1 of each year, beginning on December 1, 2007. The Notes will mature on June 1, 2017. The Company may redeem the Notes for cash in whole, at any time, or in part, from time to time, prior to maturity, at redemption prices that include accrued and unpaid interest, as specified in the Indenture and Officer’s Certificate. Notices of redemption will be mailed by first class mail at least 30 but not more than 60 days before the redemption date to each holder of notes. The Indenture limits the ability of the Company to incur certain liens, or consolidate, merge or sell all or substantially all of its assets. The Notes will be unsecured and unsubordinated obligations of the Company and will rank equally with all of the Company’s existing and future unsecured and unsubordinated indebtedness from time to time outstanding. The Indenture also contains customary event of default provisions. In the event of the occurrence of both (1) a change of control of the Company and (2) a below investment grade rating by any two of Fitch, Inc., Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., within a specified period, the Company will be required to make an offer to purchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to the date of repurchase.
The public offering price of the Notes was 99.769% of the principal amount. The Company expects to receive net proceeds (before expenses) of approximately $296.3 million and to use such net proceeds to repay existing indebtedness incurred under a $300 million term loan agreement entered into on June 23, 2006.
The Notes were offered and sold pursuant to the Company’s automatic shelf registration statement, as defined in Rule 405 of the General Rules and Regulations under the Securities Act of 1933, as amended, on Form S-3 (Registration No. 333-142960), filed with the Securities and Exchange Commission (the “SEC”) on May 15, 2007. The Company has filed with the SEC a prospectus supplement, dated May 15, 2007, together with the accompanying prospectus, dated May 15, 2007, relating to the offering and sale of the Notes.
The above description of the Underwriting Agreement, the Indenture, the Officer’s Certificate and the Notes is qualified in its entirety by reference to the Underwriting
2
Agreement, the Indenture, the Officer’s Certificate, the form of Note, each of which is incorporated herein by reference and are attached to this Current Report on Form 8-K as Exhibits 1, 4.1, 4.2 and 4.3, respectively.
Some of the underwriters and their affiliates have engaged in, and in the future may engage in, investment banking transactions with, and provide services to, the Company or the Company’s subsidiaries in the ordinary course of business. In particular, an affiliate of Banc of America Securities LLC is the administrative agent and affiliates of certain of the underwriters are lenders under the Company’s $700 million revolving credit facility. An affiliate of J.P. Morgan Securities Inc. is the administrative agent and affiliates of certain of the underwriters are lenders under the Company’s $300 million term loan facility and may receive a portion of the amounts to be repaid under the term loan facility from the net proceeds of this offering.
| Item 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off- Balance Sheet Arrangement of a Registrant |
The information set forth in Item 1.01 above with respect to the Notes is hereby incorporated by reference into this Item 2.03, insofar as it relates to the creation of a direct financial obligation.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits. The following exhibits are filed with this Form 8-K: |
Exhibit No. | Description of Exhibits | |
1 | Underwriting Agreement, dated May 15, 2007, by and among Health Net, Inc. and J.P. Morgan Securities Inc., Banc of America Securities LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein. | |
4.1 | Indenture, dated as of May 18, 2007, by and between Health Net Inc. as issuer, and The Bank of New York Trust Company, N.A., as trustee. | |
4.2 | Officer’s Certificate, dated May 18, 2007, establishing the terms and form of the Notes. | |
4.3 | Form of Note (included in Exhibit 4.2 above). | |
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
May 18, 2007
| HEALTH NET, INC. | ||
| By: | /s/ Linda V. Tiano | |
| Name: | Linda V. Tiano | |
| Title: | Senior Vice President, General Counsel and Secretary | |
4
EXHIBIT INDEX
Exhibit No. | Description | |
1 | Underwriting Agreement, dated May 15, 2007, by and among Health Net, Inc. and J.P. Morgan Securities Inc., Banc of America Securities LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein. | |
4.1 | Indenture, dated as of May 18, 2007, by and between Health Net, Inc. as issuer, and The Bank of New York Trust Company, N.A., as trustee. | |
4.2 | Officer’s Certificate, dated May 18, 2007, establishing the terms and form of the Notes. | |
4.3 | Form of Note (included in Exhibit 4.2 above). | |
5
